Advertisement
"The DL900 was enthusiastically received at both ACC and HRS," HarryStrandquist, President and CEO of Braemar, Inc. commented. "Our partners arein the process of integrating this new device into their ambulatory cardiacmonitoring product lines."
Advertisement
The DL900 increases diagnostic yield and provides extended recording timeof several days or more for clinical research applications. The devicecombines high speed USB transfer capability with the ability to use aremovable SD memory card. The DL900 provides high-resolution recordings aswell as high sampling rate options suitable for both clinical and researchapplications. A programmable pacemaker detection capability provides theclinician with additional data.
The DL900's advanced technology platform has the capacity to supportnumerous OEM capabilities, including multi parameter recording and datastorage of a variety of physiological signals.
For photo, go to http://www.biotelinc.com/images/BraemarDL900.jpg.
Braemar, Inc., designs, develops, engineers and manufactures ambulatorycardiac monitoring and other medical devices. The company provides high-quality, reliable devices to OEM partners worldwide.
SOURCE Biotel, Inc.
